A detailed history of Aigen Investment Management, LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Aigen Investment Management, LP holds 6,157 shares of LEGN stock, worth $262,165. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,157
Holding current value
$262,165
% of portfolio
0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$43.55 - $59.88 $268,137 - $368,681
6,157 New
6,157 $300,000
Q3 2023

Nov 13, 2023

SELL
$63.16 - $76.5 $541,344 - $655,681
-8,571 Reduced 64.27%
4,765 $320,000
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $617,190 - $1 Million
13,336 New
13,336 $920,000
Q3 2021

Nov 12, 2021

SELL
$35.31 - $50.56 $198,724 - $284,551
-5,628 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$25.8 - $41.09 $145,202 - $231,254
5,628 New
5,628 $231,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.13B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.